Johnson & Johnson Reports 2020 Second-Quarter Results:
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall St set to gain on tech rebound, Middle East in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Axsome Therapeutics (AXSM) PT Raised to $380 at Jefferies
Johnson & Johnson (JNJ) Tops Q2 EPS by 19c, Offers FY Guidance
July 16, 2020 6:42 AM EDTJohnson & Johnson (NYSE: JNJ) reported Q2 EPS of $1.67, $0.19 better than the analyst estimate of $1.48. Revenue for the quarter came in at $18.34 billion versus the consensus estimate of $17.5 billion.
GUIDANCE:
Johnson & Johnson sees FY2020 EPS of $7.75-$7.95, versus the... More
